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which has been demonstrated to be associated with
significantly higher rates of thrombosis.10
Finally, this article written by surgeons about
haemodialysis with no collaboration with a nephrol-
ogist or a radiologist reflects all the drawbacks of a
wholly surgical approach in the management of
vascular access in 2003: such surgeons give the
impression that they favour graft placement because
the most frequent complications of grafts are easier to
manage by conventional surgery whereas the less
frequent complications of autogenous fistulae are
much better handled by interventional radiology.
How long will responsible nephrologists tolerate
such a policy?
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Re: Role of Superficial Venous Surgery in Patients with
Combined Superficial and Segmental Deep Venous Reflux
M.S. Gohel, J.R. Barwell, K.R. Poskitt and M.R. Whyman*
Department of Vascular Surgery, Cheltenham General Hospital, Sandford Road, Cheltenham, Gloucestershire
GL53 7AN, UK
The article by Adam et al.1 reported that segmental deep
venous reflux is often corrected following surgical
correction of superficial venous reflux. Our unit has
had similar results in patients with chronic venous
ulceration. Interestingly, we have found that segmental
deep reflux is also reversed in some legs treated with
compression alone (unpublished data). This supports
the authors’ hypothesis that segmental deep reflux may
be secondary to volume/pressure overload from reflux-
ing superficial segments. Superficial venous surgery or
compression treatment may offload the deep venous
compartment sufficiently to reduce volume/pressure
overload and reverse reflux.
In addition to anatomical benefits, we feel that
superficial venous surgery has haemodynamic and
clinical advantages in patients with mixed superficial
and segmental deep reflux. We have shown a
significant improvement in venous refill time as
assessed by digital photoplethysmography in this
group of patients (unpublished data). Moreover,
these patients have a reduced ulcer recurrence rate
following surgery when compared to legs treated with
compression alone.2
We support the authors’ conclusions that superficial
venous surgery has an extended role in patients with
mixed superficial and segmental deep venous reflux
and chronic venous ulceration.
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Re: Overview of the Principal Results and Secondary
Analyses from the European and North American
Randomised Trials of Endarterectomy for Symptomatic
Carotid Stenosis
M. Adiseshiah,
Vascular/Endovascular Unit, University College London Hospitals, 149, Harley Street, London WIG 6DE,
UK
It was with interest that I read the above paper. The
previous study by Rothwell et al.1 makes clear the sub-
groups of patients with symptomatic carotid stenosis
and who would benefit most and least from carotid
endarterectomy.
The conclusion by Naylor, Rothwell and Bell that
units should quote their own results for stroke/death at
30 days is extremely important. It is unjustified to apply
published results to other units unassociated with said
publications. Over the last two decades, most specialist
units have found a stroke/death risk in symptomatic
patients of approximately 2% validated by neurologists.
This comprises 0% ipsilateral stroke, but with MI death,
contralateral stroke and cerebral haemorrhage from
reperfusion, contributing to the overall 2%.
In the UK, with league tables now in fashion, it would
be useful for patients and doctors alike, if carotid
endarterectomies were publicly audited and published
as they were last year for aortic aneurysm repair.
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Re: Review: Overview of the Principal Results and
Secondary Analyses from the European and North
American Randomised Trials of Endarterectomy for
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It was with interest that I read the above paper. The
previous study by Rothwell et al. makes clear the
subgroups of patients with symptomatic carotid
stenosis and who would benefit most and least from
carotid endarterectomy.
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